Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. - Wikidata - awgldk - TriplyDB

Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis.

Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis.

http://www.wikidata.org/entity/Q34316358

about

Interventions for preventing oral mucositis for patients with cancer receiving treatment Interventions for preventing oral mucositis for patients with cancer receiving treatment Interventions for preventing oral mucositis for patients with cancer receiving treatment Interventions for preventing oral mucositis for patients with cancer receiving treatment The molecular immunology of mucositis: implications for evidence-based research in alternative and complementary palliative treatments.Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice Treatment of oral mucositis due to chemotherapy Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging Treatments Palifermin: role in the prevention of chemotherapy- and radiation-induced mucositis Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective Functioning and health in patients with cancer on home-parenteral nutrition: a qualitative study.Low-level laser therapy: a standard of supportive care for cancer therapy-induced oral mucositis in head and neck cancer patients?Chemotherapy- and radiotherapy-induced oral mucositis: review of preventive strategies and treatment.Influence of low-energy laser in the prevention of oral mucositis in children with cancer receiving chemotherapy.Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum Noninvasive direct detection of ocular mucositis by in vivo confocal microscopy in patients treated with S-1 Traumeel S in preventing and treating mucositis in young patients undergoing SCT: a report of the Children's Oncology Group.Protein calorie malnutrition, nutritional intervention and personalized cancer care.Oral Mucositis: Melatonin Gel an Effective New Treatment.New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury Effect of intraoral low-level laser therapy on quality of life of patients with head and neck cancer undergoing radiotherapy.Relationship between manometric and videofluoroscopic measures of swallow function in healthy adults and patients treated for head and neck cancer with various modalities.Efficacy of CR3294, a new benzamidine derivative, in the prevention of 5-fluorouracil-induced gastrointestinal mucositis and diarrhea in mice The Role of Supportive Therapy in the Era of Modern Adjuvant Treatment - Current and Future Tools.MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.Oral complications of cancer and cancer therapy: from cancer treatment to survivorship.Mucositis and salivary antioxidants in patients undergoing bone marrow transplantation (BMT)Adverse event management of oral mucositis in patients with breast cancer Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients.Herbal substance, acteoside, alleviates intestinal mucositis in mice.Effect of low level laser therapy in the reduction of oral complications in patients with cancer of the head and neck submitted to radiotherapy.Preliminary estimation of the prevalence of chemotherapy-induced dysgeusia in Japanese patients with cancer.Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities.The role of Smad7 in oral mucositis.Oral mucositis induced by anticancer treatments: physiopathology and treatments.Morphine mouthwash for the management of oral mucositis in patients with head and neck cancer Effect of low-level laser therapy on inflammatory mediator release during chemotherapy-induced oral mucositis: a randomized preliminary study.The role of Wnt/β-catenin signaling in enterocyte turnover during methotrexate-induced intestinal mucositis in a rat.Sunitinib in metastatic renal cell carcinoma: recommendations for management of noncardiovascular toxicities.

P2860

Q24235217-64BBD2B6-53B9-457C-8E72-8D98BADA69D0 Q24235482-063E5787-A26A-45F5-9A46-6E94CFCD331F Q24243046-62BED264-25A8-40EE-87B4-8641A29542E8 Q24246310-49CFEAA6-EC6D-4AA1-A597-DFE9A834FA61 Q24812445-CF0F501D-4EA0-439E-A3E1-3F090D88EEAE Q26743390-4E8AAFD3-1E43-4E89-89A7-98A421394E63 Q26749050-2BEB9225-8014-4EC0-A053-44973BBEA6A4 Q26830695-4B3D9B24-06B2-423C-8B54-1B9CEE9FACB0 Q28079705-2E51917E-8C21-440A-A5D3-CC9F499C1FB4 Q28280759-8D288FE3-40C8-46E0-97CC-ED1C9A42DF2E Q28388806-0F3155A3-CB73-4FC4-AA03-CE18CDEC3A37 Q30494289-3379A4F6-7051-4724-BEEC-BF4F3B4511F1 Q31151263-9C4D3324-ED7C-44EB-BBB2-30EC6287E38F Q33217865-E0B8638C-7A52-4140-803F-AFF37D83DC9A Q33251485-0D7F3645-28D3-4DD8-939D-588A5F8EB06C Q33293726-BA321D5A-5FD0-4FEF-BAA8-D2ECB5CC4FF5 Q33522631-B1A21BE8-EC80-417B-BBFF-3939DFBEBEEB Q33559486-6701B3C5-1019-4232-AFC4-24729A2DB164 Q33618955-559642B6-26E9-406E-AEE0-24E2FB69983C Q33755115-8351CB73-819D-4ABE-BC05-679638CA2711 Q33774917-764D174A-1F46-41A0-AF92-459EEB78BD73 Q33864959-D63543A2-55E6-4122-B995-8E967C527A10 Q33944059-D2D3AE90-2809-406D-B991-4CFC78F220BC Q34080590-D4CA4ADC-8F29-4FAA-B234-A4D1A39E0D87 Q34095827-D91267EB-F3FA-4C3C-AC1F-4254D5E43C85 Q34180792-1E0A1E46-D738-4F3F-B0C3-CE9CDEBCFA9C Q34299445-87BCED12-AC59-431B-9C1D-E616632F3AD5 Q34317762-5991512F-1B8F-418A-AD21-9D17DFF8A56B Q34403510-1FD145CD-7CEA-4541-B9CE-C800D2F542D0 Q34419150-C4C3D9C3-08AB-46EE-A895-B57F56D92E2E Q34988751-C3A42B7C-9E50-44CF-B177-66F331926CCB Q35027143-A9115D3C-9F27-465C-97D2-284CC9304F0F Q35027279-F437277B-E091-47BF-A0CB-DCD6831ED2A5 Q35083960-6E72EDD3-6821-4B3A-AAD6-C02C60B01E17 Q35143104-96B05F7C-D384-4ADB-932E-1E9E7D8C4017 Q35166803-415CA716-3FF6-4A2B-AC41-396D504EB975 Q35172429-71D4DECE-44BF-44EA-8DDE-3687FA67E965 Q35209103-57527D0E-01FD-42F0-B724-36A52B9B3918 Q35398954-112DE2AE-782E-476E-952F-B8011229E4F4 Q35584920-AA884FB9-E899-41B8-BD18-B3FC7DFAF431

P2860

Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis.

http://www.wikidata.org/entity/Q34316358

description

2004 nî lūn-bûn

@nan

2004 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Clinical practice guidelines f ...... nd gastrointestinal mucositis.

@ast

Clinical practice guidelines f ...... nd gastrointestinal mucositis.

@en

Clinical practice guidelines f ...... nd gastrointestinal mucositis.

@nl

type

label

Clinical practice guidelines f ...... nd gastrointestinal mucositis.

@ast

Clinical practice guidelines f ...... nd gastrointestinal mucositis.

@en

Clinical practice guidelines f ...... nd gastrointestinal mucositis.

@nl

prefLabel

Clinical practice guidelines f ...... nd gastrointestinal mucositis.

@ast

Clinical practice guidelines f ...... nd gastrointestinal mucositis.

@en

Clinical practice guidelines f ...... nd gastrointestinal mucositis.

@nl

P1433

Q34316358-19CA8E37-3DAF-45EC-8B72-48FB99D72EC0

P1476

Q34316358-7A0799AF-F6B1-471D-AF48-36B4E797C712

P2093

Q34316358-19572DF9-48D2-4803-9362-4978A6D80971

Q34316358-1A8F6DA5-7AB1-46C5-A614-35FFB5674B15

Q34316358-1B2114C4-6B8F-4FED-8CEE-551E3817B9B1

Q34316358-3B09CB8D-19E1-48AB-BB84-644090CF416A

Q34316358-4BA267FA-335B-4D0C-AA43-FC39F39846DF

Q34316358-6CF982E7-B479-4DB0-A9A3-ED15BA7C57D4

Q34316358-90C84CA8-7455-443A-8721-D5ADA17493D5

Q34316358-96864C33-8D85-4065-BB31-58D8C1A9063A

Q34316358-BFA91844-2FD1-42ED-B89F-195D81EBF20F

Q34316358-C476F20B-CE1A-45DF-846A-AEA2CD4D00B1

P2860

Q34316358-050518AD-3599-4D06-9E60-2198A42543DC

Q34316358-081E555B-8BD6-4491-8944-91F1813F4294

Q34316358-53095CF2-CFD4-4DE9-A048-369A4A841A85

Q34316358-66E52585-D1AB-4C87-988D-86CDE34389DD

Q34316358-C3825204-9CBC-45D1-ADF7-8A266B223534

Q34316358-E14F4BF1-0235-4AC0-A3C8-0E92A23E578D

Q34316358-EB281C5F-106D-48D2-A0CE-FBA5782180B4

P304

Q34316358-0692FD92-CCDB-4B78-B920-A2C88D67F45D

P31

Q34316358-A8AFF5AE-E5A7-4608-BC9E-02E28D4FF5C4

P356

Q34316358-63C9B8C6-558F-4088-AD14-FB0432A4E338

P407

Q34316358-D3619A93-7C3D-41F9-8EA8-98A41997D2C8

P433

Q34316358-1B3ECE80-C645-4FFF-A2D5-1CF635A30F9F

P478

Q34316358-8BECED10-6EDF-4F8F-8E4C-1DC7343BA948

P577

Q34316358-769E0A16-1A63-4A7E-9BAC-E5E15176D976

P5875

Q34316358-E3B4877B-9184-44EF-9471-83C1FDD478C5

P698

Q34316358-77535A40-0D9D-4B79-AAAE-99E993699328

P356

P1433

P1476

Clinical practice guidelines f ...... nd gastrointestinal mucositis.

@en

P2093

Catherine Cooksley

http://www.w3.org/2001/XMLSchema#string

Deborah McGuire

http://www.w3.org/2001/XMLSchema#string

Dorothy Keefe

http://www.w3.org/2001/XMLSchema#string

Douglas E Peterson

http://www.w3.org/2001/XMLSchema#string

Edward B Rubenstein

http://www.w3.org/2001/XMLSchema#string

International Society for Oral Oncology

http://www.w3.org/2001/XMLSchema#string

Joel Epstein

http://www.w3.org/2001/XMLSchema#string

Linda S Elting

http://www.w3.org/2001/XMLSchema#string

Mark Schubert

http://www.w3.org/2001/XMLSchema#string

Mucositis Study Section of the Multinational Association for Supportive Care in Cancer

http://www.w3.org/2001/XMLSchema#string

P2860

Oral acyclovir prophylaxis against herpes simplex virus in non-Hodgkin lymphoma and acute lymphoblastic leukaemia patients receiving remission induction chemotherapy. A randomised double blind, placebo controlled trial.

Plasma prostaglandins in mucositis due to radiotherapy and chemotherapy for head and neck cancer.

Oral and pharyngeal candidiasis. Topical agents for management and prevention.

Treatment of radiation- and chemotherapy-induced stomatitis.

Phase II trial of subcutaneous amifostine in patients undergoing radiation therapy for head and neck cancer.

Clinical study of radioprotective effects of amifostine (YM-08310, WR-2721) on long-term outcome for patients with cervical cancer.

Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study.

P304

2026-2046

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.20163

http://www.w3.org/2001/XMLSchema#string

P407

P433

9 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P577

2004-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227526546

http://www.w3.org/2001/XMLSchema#string

P698

15108223

http://www.w3.org/2001/XMLSchema#string